These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16414520)

  • 21. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study.
    Pediatric Eye Disease Investigator Group
    Am J Ophthalmol; 2003 Oct; 136(4):620-9. PubMed ID: 14516801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study.
    Holmes JM; Beck RW; Kraker RT; Cole SR; Repka MX; Birch EE; Felius J; Christiansen SP; Coats DK; Kulp MT;
    Arch Ophthalmol; 2003 Nov; 121(11):1625-32. PubMed ID: 14609923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False amblyopia prediction in strabismic patients by fixation preference testing correlates with contralateral ocular dominance.
    AlHarkan DH; Khan AO
    J AAPOS; 2014 Oct; 18(5):453-6. PubMed ID: 25266829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and treatment of amblyopia.
    Bradfield YS
    Am Fam Physician; 2013 Mar; 87(5):348-52. PubMed ID: 23547551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amblyopia treatment and quality of life: the child's perspective on atropine versus patching.
    Steel DA; Codina CJ; Arblaster GE
    Strabismus; 2019 Sep; 27(3):156-164. PubMed ID: 31329017
    [No Abstract]   [Full Text] [Related]  

  • 27. [The lazy eye - contemporary strategies of amblyopia treatment].
    Sturm V
    Praxis (Bern 1994); 2011 Feb; 100(4):229-35. PubMed ID: 21328237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atropine vs. patching for the treatment of moderate amblyopia in children.
    Kushner BJ
    Arch Ophthalmol; 2002 Mar; 120(3):387-8. PubMed ID: 11879145
    [No Abstract]   [Full Text] [Related]  

  • 29. Amblyopia in children aged 7 to 17 years.
    Phillips CI
    Arch Ophthalmol; 2006 Nov; 124(11):1668; author reply 1668-9. PubMed ID: 17102030
    [No Abstract]   [Full Text] [Related]  

  • 30. Visual outcome and success of amblyopia treatment in unilateral small posterior lens opacities and lenticonus initially treated nonsurgically.
    Travi GM; Schnall BM; Lehman SS; Kelly CJ; Hug D; Hirakata VN; Calhoun JH
    J AAPOS; 2005 Oct; 9(5):449-54. PubMed ID: 16213394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strabismus might be a risk factor for amblyopia recurrence.
    Nilsson J; Baumann M; Sjöstrand J
    J AAPOS; 2007 Jun; 11(3):240-2. PubMed ID: 17419081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatives to patching.
    Sudarshan AP
    Ophthalmology; 1998 Aug; 105(8):1351. PubMed ID: 9709736
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of media press coverage on parental preferences in amblyopia treatment.
    Golden RP; Olitsky SE
    J AAPOS; 2005 Jun; 9(3):212-5. PubMed ID: 15956939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline and Clinical Factors Associated with Response to Amblyopia Treatment in a Randomized Clinical Trial.
    Birch EE; Jost RM; Kelly KR; Leffler JN; Dao L; Beauchamp CL
    Optom Vis Sci; 2020 May; 97(5):316-323. PubMed ID: 32413002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the treatment of amblyopia.
    Quinn GE; Beck RW; Holmes JM; Repka MX;
    Pediatrics; 2004 Jun; 113(6):1800-2. PubMed ID: 15173508
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of amblyopia.
    Holmes JM; Repka MX; Kraker RT; Clarke MP
    Strabismus; 2006 Mar; 14(1):37-42. PubMed ID: 16513568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contradictions in the amblyopia treatment studies.
    Lempert P
    Arch Ophthalmol; 2006 Feb; 124(2):285; author reply 285-7. PubMed ID: 16476906
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Amblyopia and Amblyopia Risk Factors Based on Current Evidence.
    Koo EB; Gilbert AL; VanderVeen DK
    Semin Ophthalmol; 2017; 32(1):1-7. PubMed ID: 27748640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penalization versus part-time occlusion and binocular outcome in treatment of strabismic amblyopia.
    Simons K; Gotzler KC; Vitale S
    Ophthalmology; 1997 Dec; 104(12):2156-60. PubMed ID: 9400778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The development of occlusion amblyopia following atropine therapy for strabismic amblyopia].
    Kubota N; Usui C
    Nippon Ganka Gakkai Zasshi; 1993 Jun; 97(6):763-8. PubMed ID: 8328347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.